| scholarly article | Q13442814 |
| P50 | author | Vladislav S. Korsak | Q61639554 |
| Siladitya Bhattacharya | Q56850224 | ||
| P2093 | author name string | A Nyboe Andersen | |
| V Goossens | |||
| K G Nygren | |||
| A P Ferraretti | |||
| J de Mouzon | |||
| J A Castilla | |||
| M Kupka | |||
| Consortium for the European Society on Human Reproduction and Embryology (ESHRE) | |||
| European IVF-Monitoring (EIM) | |||
| P2860 | cites work | Assisted reproductive technology in Europe, 2001. Results generated from European registers by ESHRE | Q57530436 |
| Assisted reproductive technology in Europe, 1997. Results generated from European registers by ESHRE. European IVF-Monitoring Programme (EIM), for the European Society of Human Reproduction and Embryology (ESHRE) | Q73397109 | ||
| Trends in the use of intracytoplasmic sperm injection in the United States | Q80624545 | ||
| Assisted reproductive technology in Europe, 2002. Results generated from European registers by ESHRE | Q83057252 | ||
| ESHRE PGD Consortium data collection VI: cycles from January to December 2003 with pregnancy follow-up to October 2004. | Q31080930 | ||
| Trends in the use of intracytoplasmatic sperm injection marked variability between countries | Q37245639 | ||
| Assisted reproductive technology in Europe, 2006: results generated from European registers by ESHRE. | Q44024174 | ||
| World collaborative report on Assisted Reproductive Technology, 2002. | Q44743073 | ||
| Assisted reproductive technology and intrauterine inseminations in Europe, 2005: results generated from European registers by ESHRE: ESHRE. The European IVF Monitoring Programme (EIM), for the European Society of Human Reproduction and Embryology (E | Q45013228 | ||
| The International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) Revised Glossary on ART Terminology, 2009. | Q46377235 | ||
| International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) revised glossary of ART terminology, 2009. | Q48667199 | ||
| Assisted reproductive technology in Europe, 2004: results generated from European registers by ESHRE. | Q48764590 | ||
| Assisted reproductive technology in Europe, 2003. Results generated from European registers by ESHRE. | Q48794067 | ||
| Assisted reproductive technology in Europe, 1999. Results generated from European registers by ESHRE. | Q48844413 | ||
| Assisted reproductive technology in Europe, 1998. Results generated from European registers by ESHRE. European Society of Human Reproduction and Embryology | Q48875387 | ||
| Assisted reproductive technology in Europe, 2000. Results generated from European registers by ESHRE. | Q50678839 | ||
| The ICMART glossary on ART terminology | Q53252387 | ||
| The International Committee Monitoring Assisted Reproductive Technologies (ICMART) glossary on ART terminology | Q53254351 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 954-966 | |
| P577 | publication date | 2012-02-17 | |
| P1433 | published in | Human Reproduction | Q5937357 |
| P1476 | title | Assisted reproductive technology in Europe, 2007: results generated from European registers by ESHRE. | |
| P478 | volume | 27 |
| Q36714818 | A closed system supports the developmental competence of human embryos after vitrification : Closed vitrification of human embryos |
| Q36693913 | Amino acid turnover by human oocytes is influenced by gamete developmental competence, patient characteristics and gonadotrophin treatment. |
| Q47394116 | Assisted reproductive technology in Europe, 2008: results generated from European registers by ESHRE. |
| Q45352029 | Assisted reproductive technology in Europe, 2009: results generated from European registers by ESHRE. |
| Q40134009 | Assisted reproductive technology in Europe, 2011: results generated from European registers by ESHRE. |
| Q43596811 | Beneficial effect of melatonin on blastocyst in vitro production from heat-stressed bovine oocytes |
| Q53590442 | Beneficial effects of melatonin on in vitro bovine embryonic development are mediated by melatonin receptor 1. |
| Q46901229 | Biological risk versus socio-economic advantage: low birth-weight, multiple births and income variations among Irish infants born following fertility treatments |
| Q45203584 | Birth defects in medically assisted reproduction pregnancies in the city of Barcelona. |
| Q36797926 | Clinical outcome after IMSI procedure in an unselected infertile population: a pilot study |
| Q57710235 | Contribution of maternal age to preterm birth rates in Denmark and Quebec, 1981-2008 |
| Q50560312 | Costs of medically assisted reproduction treatment at specialized fertility clinics in the Danish public health care system: results from a 5-year follow-up cohort study |
| Q55122140 | Cryopreservation in ART and concerns with contamination during cryobanking. |
| Q33726242 | Demographic relevancy of increased use of assisted reproduction in European countries. |
| Q35157216 | Detection and phasing of single base de novo mutations in biopsies from human in vitro fertilized embryos by advanced whole-genome sequencing |
| Q28302387 | Differential diagnosis of azoospermia with proteomic biomarkers ECM1 and TEX101 quantified in seminal plasma |
| Q38070236 | Do assisted-reproduction twin pregnancies require additional antenatal care? |
| Q32184276 | Effect of L-carnitine on in vitro developmental rate, the zona pellucida and hatching of blastocysts and their cell numbers in mouse embryos |
| Q36147062 | Effect of endometrial biopsy on intrauterine insemination outcome in controlled ovarian stimulation cycle |
| Q30747725 | Efficacy, safety, and trends in assisted reproductive technology in Japan-analysis of four-year data from the national registry system |
| Q85554884 | Evaluation of an effective multifaceted implementation strategy for elective single-embryo transfer after in vitro fertilization |
| Q34330936 | Failures (with some successes) of assisted reproduction and gamete donation programs |
| Q43503500 | Follow-up of children conceived by assisted reproductive technologies |
| Q27000656 | Freeze-all policy: is it time for that? |
| Q37704094 | From fresh heterologous oocyte donation to autologous oocyte banking |
| Q36663447 | Gene Expression Profiling of Human Oocytes Developed and MaturedIn VivoorIn Vitro |
| Q38075689 | GnRH agonist triggering: recent developments |
| Q45343019 | IVF versus spontaneous twin pregnancies--which are at higher risk of complications? |
| Q41603395 | In vitro fertilization and intracytoplasmic sperm injection: current medical aspects |
| Q36695145 | Meckel-Gruber Syndrome: a population-based study on prevalence, prenatal diagnosis, clinical features, and survival in Europe |
| Q45055367 | Neonatal outcome following new assisted reproductive technology regulations in Turkey - a nationwide multicenter point prevalence study |
| Q34113005 | Obstetric outcomes of monochorionic pregnancies conceived following assisted reproductive technology: A retrospective study |
| Q36086851 | Oocyte activation and phospholipase C zeta (PLCζ): diagnostic and therapeutic implications for assisted reproductive technology |
| Q53027678 | Ovarian stimulation using human chorionic gonadotrophin impairs blastocyst implantation and decidualization by altering ovarian hormone levels and downstream signaling in mice |
| Q42446139 | Preimplantation genetic diagnosis (PGD) influences adrenal development and response to cold stress in resulting mice |
| Q34852649 | Preterm birth time trends in Europe: a study of 19 countries |
| Q35150515 | Prevalence, prenatal diagnosis and clinical features of oculo-auriculo-vertebral spectrum: a registry-based study in Europe |
| Q48644233 | Prevention of multiple pregnancies in infertility treatment |
| Q44399008 | Risk disparities in the globalisation of assisted reproductive technology: The case of Asia |
| Q37153514 | Selection of euploid blastocysts for cryopreservation with array comparative genomic hybridization (aCGH) results in increased implantation rates in subsequent frozen and thawed embryo transfer cycles |
| Q36861574 | Seminal biomarkers for the evaluation of male infertility. |
| Q38202841 | Seminal plasma as a diagnostic fluid for male reproductive system disorders |
| Q38421762 | Socio-demographic and fertility-related characteristics and motivations of oocyte donors in eleven European countries |
| Q38182704 | Systematic evaluation of the quality of clinical practice guidelines on the use of assisted reproductive techniques |
| Q35100099 | The Desire for Multiple Pregnancy among Patients with Infertility and Their Partners |
| Q44649214 | The Transition of Care from Fertility Specialists to Obstetricians: Maternal Adjustment and Postpartum Depressive Symptoms |
| Q28278102 | The ageing ovary and uterus: new biological insights |
| Q46003146 | The diversity of regulation and public financing of IVF in Europe and its impact on utilization |
| Q24608739 | The effects of acupuncture on rates of clinical pregnancy among women undergoing in vitro fertilization: a systematic review and meta-analysis |
| Q44590004 | The impact of social relations among men and women in fertility treatment on the decision to terminate treatment |
| Q47211879 | The influence of IVF/ICSI treatment on human embryonic growth trajectories |
| Q38162759 | The study of mammalian oocyte competence by transcriptome analysis: progress and challenges |
| Q93118935 | Trends over 15 years in ART in Europe: an analysis of 6 million cycles |
| Q24202455 | Vasodilators for women undergoing assisted reproduction |
| Q57470699 | Vasodilators for women undergoing fertility treatment |
| Q24193109 | Vasodilators for women undergoing fertility treatment |
| Q36620454 | Why we should talk about compliance with assisted reproductive technologies (ART): a systematic review and meta-analysis of ART compliance rates |
| Q37605336 | miR-142-3p as a biomarker of blastocyst implantation failure - A pilot study |
Search more.